Hepatocellular carcinoma
Hepatocellular carcinoma | |
Hepatocellular Carcinoma, Hepatitis C positive. Tumor growth in portal vein |
Hepatocellular carcinoma Microchapters |
Differentiating Hepatocellular carcinoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Hepatocellular carcinoma On the Web |
American Roentgen Ray Society Images of Hepatocellular carcinoma |
Risk calculators and risk factors for Hepatocellular carcinoma |
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]
Synonyms and keywords: Hepatoma; malignant hepatoma; liver cancer; malignant liver tumor; primary liver cell carcinoma; hepatic cancer
Overview
Historical perspective
Pathophysiology
Causes
Differentiating Hepatocellular carcinoma from other Diseases
Epidemiology & Demographics
Risk factors
Screening
Natural History, Complications & Prognosis
Diagnosis
History and Symptoms | Physical Examination | Staging | Lab Studies | Electrocardiogram | Chest X Ray | MRI | CT | Ultrasound | Other imaging findings | Other diagnostic studies
Treatment
Medical Therapy: Percutaneous ethanol injection | Transcatheter arterial chemoembolization (TACE) | Sealed source radiotherapy | Radiofrequency ablation (RFA) | Intra-arterial iodine-131–lipiodol administration | High intensity focused ultrasound (HIFU) | Hormonal therapy | Chemotherapy
Contraindicated medications
Hepatocellular carcinoma is considered an absolute contraindication to the use of the following medications:
- Drospirenone and Ethinyl estradiol
- Norethindrone acetate and Ethinyl estradiol
- Norgestimate and Ethinyl estradiol
- Norgestrel and Ethinyl estradiol
- Hydroxyprogesterone caproate
Surgery: Liver transplant | Surgical resection | Cryosurgery
Prevention: Primary prevention | Secondary prevention
Resources
Template:Gastroenterology
Template:Tumors
Template:Tumor morphology